CAS: 419547-11-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | NAV 2729 REF: IN-DA01ENJWCAS: 419547-11-8 | 98% | 63.00 €~537.00 € | Wed 08 Jan 25 |
 | NAV-2729 REF: 54-BISN0060CAS: 419547-11-8 | 98% | 60.00 € | Thu 09 Jan 25 |
 | NAV-2729 REF: TM-T5142CAS: 419547-11-8 | 98.83% - 98.91% | 45.00 €~922.00 € | Wed 15 Jan 25 |
 | NAV 2729 REF: 3D-URA54711CAS: 419547-11-8 | Min. 95% | To inquire | Wed 19 Feb 25 |
Ref: IN-DA01ENJW
| 1mg | 63.00 € | ||
| 5mg | 120.00 € | ||
| 25mg | 487.00 € | ||
| 50mg | 537.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: 54-BISN0060
| 5mg | 60.00 € |
Estimated delivery in United States, on Thursday 9 Jan 2025
NAV-2729
CAS:419547-11-8
NAV-2729 inhibits six ArfGEFs (human ARNO, EFA6, BIG1, and BRAG2 and Legionella and Rickettsia RalF), …
Formula:
C25H17ClN4O3
Purity:
98.83% - 98.91%
Color and Shape:
Solid
Molecular weight:
456.88
Ref: TM-T5142
| 2mg | 45.00 € | ||
| 5mg | 66.00 € | ||
| 10mg | 94.00 € | ||
| 25mg | 201.00 € | ||
| 50mg | 297.00 € | ||
| 100mg | 446.00 € | ||
| 500mg | 922.00 € | ||
| 1mL*10mM (DMSO) | 75.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
NAV 2729
CAS:419547-11-8
NAV 2729 is a small molecule drug that inhibits the activity of fatty acid synthase …
Formula:
C25H17ClN4O3
Purity:
Min. 95%
Molecular weight:
456.88 g/mol
Ref: 3D-URA54711
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
